AI-redesigned starting points and outcomes enhance protein evolution

Abstract Engineered or laboratory-evolved proteins often have suboptimal stability, activity or specificity. Here we applied artificial intelligence (AI)-based protein sequence design to address challenges in experimental enzyme evolution. Using the model ProteinMPNN, we redesigned three distinct botulinum neurotoxin (BoNT) proteases, generating variants with improved stability and full catalytic efficiency 1 . We hypothesized that redesigned enzymes may be more mutationally robust than their wild-type (WT) counterparts, and therefore may serve as better starting points to evolve new function. We performed side-by-side phage-assisted continuous evolution campaigns initiated with AI-redesigned proteases or with the corresponding WT proteases 2 . Evolving three distinct redesigned enzymes as starting points consistently yielded proteases with higher activity than evolving WT proteases in the same selection. Across four evolution campaigns, redesign conferred robustness that unlocked access to otherwise inaccessible highly functional sequences, confirmed by the inability of redesign-evolved mutations to function in WT enzyme backgrounds. When redesign raises fitness in sequence space local to the starting point, redesigned starting points adapt at a faster rate. Finally, we evolved both WT and AI-redesigned BoNT/E protease to selectively cleave the therapeutically relevant protein ataxin-2. Proteases evolved from the redesigned starting point reached higher catalytic efficiency and stability while minimizing native substrate cleavage, achieving more than 79-fold greater selected specificity for ataxin-2 than the best-performing variant evolved from WT BoNT/E. This study establishes a practical workflow using AI-redesigned starting points to evolve enzymes with improved properties compared with those evolved from natural proteins, with broad implications for protein science.

Authors

Institutions

Publication Details

Journal
Nature
Published
2026-07-22
DOI
https://doi.org/10.1038/s41586-026-10820-0
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI-redesigned starting points and outcomes enhance protein evolution

N Krasnow, Colin Hemez, Julia McCreary, David R. Liu et al.
Nature
Botulinum Toxin and Related Neurological Disorders
article

AI-redesigned starting points and outcomes enhance protein evolution

N Krasnow, Colin Hemez, Julia McCreary, David R. Liu, J. Y. Xu, Gandhar Mahadeshwar, Wei Jiang, Emily Zhang, Y. Allen Tao, Logan E. Brown
article en

Abstract

Abstract Engineered or laboratory-evolved proteins often have suboptimal stability, activity or specificity. Here we applied artificial intelligence (AI)-based protein sequence design to address challenges in experimental enzyme evolution. Using the model ProteinMPNN, we redesigned three distinct botulinum neurotoxin (BoNT) proteases, generating variants with improved stability and full catalytic efficiency 1 . We hypothesized that redesigned enzymes may be more mutationally robust than their wild-type (WT) counterparts, and therefore may serve as better starting points to evolve new function. We performed side-by-side phage-assisted continuous evolution campaigns initiated with AI-redesigned proteases or with the corresponding WT proteases 2 . Evolving three distinct redesigned enzymes as starting points consistently yielded proteases with higher activity than evolving WT proteases in the same selection. Across four evolution campaigns, redesign conferred robustness that unlocked access to otherwise inaccessible highly functional sequences, confirmed by the inability of redesign-evolved mutations to function in WT enzyme backgrounds. When redesign raises fitness in sequence space local to the starting point, redesigned starting points adapt at a faster rate. Finally, we evolved both WT and AI-redesigned BoNT/E protease to selectively cleave the therapeutically relevant protein ataxin-2. Proteases evolved from the redesigned starting point reached higher catalytic efficiency and stability while minimizing native substrate cleavage, achieving more than 79-fold greater selected specificity for ataxin-2 than the best-performing variant evolved from WT BoNT/E. This study establishes a practical workflow using AI-redesigned starting points to evolve enzymes with improved properties compared with those evolved from natural proteins, with broad implications for protein science.

Nature
Broad Institute (US), Howard Hughes Medical Institute (US), Harvard University (US)
Openalex Percentile: Top 8%
Botulinum Toxin and Related Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.